Quantitative and functional alterations of 6-sulfo LacNac dendritic cells in multiple myeloma

Impact of p38 mitogen-activated protein kinase inhibition on immunostimulatory properties of human 6-sulfo LacNAc dendritic cells

(2016) Saskia Langosch et al.   IMMUNOBIOLOGY

The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking

(2016) Marije B. Overdijk et al.   JOURNAL OF IMMUNOLOGY

A slan-based nomenclature for monocytes?

(2015) P. Ancuta   BLOOD

Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing

(2015) P. Leone et al.   BLOOD

Pathogenesis beyond the cancer clone(s) in multiple myeloma

(2015) G. Bianchi et al.   BLOOD

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

(2015) Marije B Overdijk et al.   mAbs

Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis

(2015) Marieta Toma et al.   OncoImmunology

Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype

(2015) Katia Beider et al.   Oncotarget

CD14+CD16+monocytes rather than CD14+CD51/61+monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study

(2014) V. Petitprez et al.   International Journal of Laboratory Hematology

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

slanDCs selectively accumulate in carcinoma-draining lymph nodes and marginate metastatic cells

(2014) William Vermi et al.   Nature Communications

Chemokines and adult bone marrow stem cells

(2012) Sara M. Rankin   IMMUNOLOGY LETTERS

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

(2011) S. V. Rajkumar et al.   BLOOD

Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses

(2011) Anja Hänsel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Nomenclature of monocytes and dendritic cells in blood

(2010) L. Ziegler-Heitbrock et al.   BLOOD

The dendritic cell–tumor cross-talk in cancer

(2010) Yuting Ma et al.   CURRENT OPINION IN IMMUNOLOGY

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

(2010) M. de Weers et al.   JOURNAL OF IMMUNOLOGY

Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

(2009) Dharminder Chauhan et al.   CANCER CELL

Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma

(2009) M Roussou et al.   LEUKEMIA

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

(2008) H. Chen et al.   BLOOD

Reciprocal activating interaction between 6-sulfo LacNAc+dendritic cells and NK cells

(2008) Rebekka Wehner et al.   INTERNATIONAL JOURNAL OF CANCER